U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

John Graham, Group CEO of Zuellig Pharma, talks about election risks, US-China tensions, and how tariffs and protectionism ...

Serenity Healthcare is a leading healthcare organization in this space, offering insightful commentary on some of the ...

In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

a leading industry group. That’s 25% larger than it was in 2019, making it bigger than the sports and pharmaceutical industries. “Growth was even stronger than we predicted,” says Katherine ...

Hyderabad: Telangana Fire Services Director General Y. Nagi Reddy emphasized the importance of conducting regular fire safety ...

Despite the relatively low profile, Tianjin Pharmaceutical's improved earnings have earned recognition from investors ...

PharmaReg and MedDevReg AfriSummit host 80+ regional and international speakers alongside over 300 pharmaceutical and medical ...